Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit.; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit.). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-FEB-2025 The reporter reported that Boostrix vaccine was administered to a patient and afterwards they realized the lowest storage temperature of this vaccine was thirty-five point four degrees Fahrenheit. Afterwards during the same call, Nurse Practitioner confirmed the lowest temperature the vaccine reached was thirty-four point six degrees Fahrenheit, which led to incorrect storage of drug.